Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Off-market insider buying at Emerald Health Therapeuti (V:EMH)

Updated Monday Feb 03, 2020 04:19 AM EDT

Emerald Health Sciences Inc., a 10% Holder, acquired 9,713,666 Common Shares on a direct ownership basis at a price of $0.290 through a prospectus or prospectus exempt offering on January 31st, 2020. This represents a $2,816,963 investment into the company's shares and an account share holdings change of 32.7%.

Emerald Health Therapeuti is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Emerald Health Therapeutics Inc is a Canada-based company engaged in the medical marijuana industry. The Company operates through Emerald Health Botanicals Inc (Botanicals), a wholly owned subsidiary and Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulations. Through Botanicals, the Company is authorized to produce and sell dried cannabis flower and cannabis oil for medical purposes. The Company operates an indoor cultivation facility in Victoria, British Columbia and, through Pure Sunfarms Corp, a joint venture with Village Farms International Inc, expands into additional greenhouses. The Company also offers analytical testing of cannabis through an interest in Northern Vine Canada Inc, a Licensed Dealer under Canadian Controlled Drugs and Substances Act. The Company is part of the Emerald Health Group, which is focused on developing pharmaceutical, botanical and nutraceutical products designed to interact with the human body's endocannabinoid system. Emerald Health Therapeutics, Inc. (EMH) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to recent regulatory filings, one insider has invested a total amount of $2,816,963.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
N/A
N/A
N/A
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Emerald Health Therapeutics, Inc. (EMH)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $EMH.CA

  • No tweets found

Stocktwits

Emerald Health Therapeutics, Inc.

  • Symbol not found.